The following represents disclosure information provided by faculty of the educational and scientific sessions. The Committee have reviewed all presented disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Striking the Balance With Next-Generation Targeted Therapies for ALK and EGFR
 
Jessica Lin
 
Employment - No Relationships to Disclose
 
Leadership - No Relationships to Disclose
 
Stock and Other Ownership Interests - No Relationships to Disclose
 
Honoraria - OncLive; Pfizer
 
Consulting or Advisory Role - Anheart Therapeutics; AstraZeneca; Bayer; Blueprint Medicines; Bristol Myers Squibb ; C4 Therapeutics; CLaiM Therapeutics; Daiichi Sankyo/Astra Zeneca; Elevation Oncology; Ellipses Pharma; Genentech; Merus; Mirati Therapeutics; Novartis; Nuvalent, Inc.; Pfizer; Regeneron; Turning Point Therapeutics; Yuhan
 
Speakers' Bureau - No Relationships to Disclose
 
Research Funding - Bayer (Inst); Elevation Oncology (Inst); Hengrui Therapeutics (Inst); Linnaeus Therapeutics (Inst); Neon Therapeutics (Inst); Novartis (Inst); Nuvalent, Inc. (Inst); Relay Therapeutics (Inst); Roche (Inst); Turning Point Therapeutics (Inst)
 
Patents, Royalties, Other Intellectual Property - No Relationships to Disclose
 
Expert Testimony - No Relationships to Disclose
 
Travel, Accommodations, Expenses - Merus; Pfizer
 
Other Relationship - No Relationships to Disclose